Posterior Wall Thickness Associates With Survival Following Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy

被引:6
|
作者
Sun, Daokun [1 ]
Schaff, Hartzell, V [1 ]
Nishimura, Rick A. [2 ]
Geske, Jeffrey B. [2 ]
Dearani, Joseph A. [1 ]
Ducharme, Merrick T. [1 ]
Ommen, Steve R. [2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
关键词
hypertrophic cardiomyopathy; posterior wall thickness; septal myectomy; LEFT-VENTRICULAR HYPERTROPHY; REGRESSION; UPDATE;
D O I
10.1016/j.jchf.2022.06.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The left ventricular (LV) posterior wall thickness (PWT) is a predictor of sudden cardiac death in pediatric patients with hypertrophic cardiomyopathy (HCM), but the prognostic importance of PWT in adults has not been examined. OBJECTIVES The goal of this study was to evaluate the association of LV PWT with late survival in adult patients undergoing septal myectomy for obstructive HCM. METHODS This single-center study reviewed 2,418 patients who underwent transaortic septal myectomy for obstructive HCM. RESULTS The median preoperative PWT was 13 (IQR: 11-15) mm. Patients with PWT >13 mm tended to have systemic hypertension (55.4% vs 49.1%; P = 0.002) and a larger body mass index (median: 30.8 [IQR: 27.1-35.1] kg/m(2) vs 29.6 [IQR: 26.1-33.9] kg/m(2); P < 0.001). Preoperatively, PWT >13 mm was associated with increased septal thickness (median: 21 [IQR: 18-24] mm vs 19 [IQR: 17-22] mm; P < 0.001), greater maximum instantaneous left ventricular outflow tract (LVOT) gradient at rest (median: 67 [IQR: 36-96] mm Hg vs 47 [IQR: 19-79] mm Hg), and increased likelihood of moderate or greater mitral valve regurgitation (54.3% vs 47.3%; P = 0.001). However, PWT was not related to the severity of limitations measured by New York Heart Association functional class (P = 0.674). After adjusting for baseline covariates, greater PWT was an independent risk factor for late mortality after septal myectomy (P = 0.003). CONCLUSIONS PWT is a newly identified predictor of reduced long-term survival after septal myectomy that is independent of septal thickness and severity of LVOT gradient. Future studies are warranted to investigate the mechanisms underlying the association and the potential usefulness of PWT in patient management. (J Am Coll Cardiol HF 2022;10:831-837) (c) 2022 by the American College of Cardiology Foundation.
引用
收藏
页码:831 / 837
页数:7
相关论文
共 50 条
  • [31] Aortic valve regurgitation following transaortic septal myectomy for obstructive hypertrophic cardiomyopathy: Incidence and in fl uence on late outcomes
    Juarez-Casso, Fernando M.
    Schaff, Hartzell, V
    Patlolla, Sri Harsha
    Todd, Austin
    Dearani, Joseph A.
    Geske, Jeffrey B.
    Ommen, Steve R.
    Nishimura, Rick A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (02) : 510 - 518
  • [32] Is there referral bias in outcomes of septal myectomy for hypertrophic cardiomyopathy?
    Calderon-Rojas, Rolando
    Nguyen, Anita
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Ommen, Steve R.
    King, Katherine S.
    Lee, Alexander T.
    Dearani, Joseph A.
    Schaff, Hartzell, V
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03) : 881 - 891
  • [33] Virtual septal myectomy for preoperative planning in hypertrophic cardiomyopathy
    Takayama, Hiroo
    Yu, Sarah N.
    Sorabella, Robert
    Leb, Jay
    Pulerwitz, Todd C.
    Cooper, Cathleen
    Argenio, Melissa
    Shimada, Yuichi J.
    Weiner, Shepard
    Ginns, Jonathan N.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (02) : 455 - 463
  • [34] Application of cryoenergy to improve septal exposure during transaortic septal myectomy in hypertrophic obstructive cardiomyopathy
    Alberto Pozzoli
    Luca Vicentini
    Stefan Thelin
    Elisabetta Lapenna
    Leif Nilsson
    Ottavio Alfieri
    General Thoracic and Cardiovascular Surgery, 2018, 66 : 243 - 245
  • [35] ANAESTHESIA MANAGEMENT OF A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY UNDERGOING MORROWS SEPTAL MYECTOMY
    Agarwal, Naresh Kumar
    Kapoor, Poonam Malhotra
    Chaudhary, Shiv
    Kiran, Usha
    INDIAN JOURNAL OF ANAESTHESIA, 2007, 51 (02) : 134 - 136
  • [36] Extended Myectomy for Hypertrophic Obstructive Cardiomyopathy
    Gao, Changqing
    Ren, Chonglei
    Xiao, Cangsong
    Wu, Yang
    Wang, Gang
    Liu, Guopeng
    Wang, Yao
    HEART SURGERY FORUM, 2012, 15 (05) : E251 - E256
  • [37] Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy
    Smith, Joshua R.
    Layrisse, Veronica
    Medina-Inojosa, Jose R.
    Berg, Jessica D.
    Ommen, Steve R.
    Olson, Thomas P.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (10) : 1066 - 1073
  • [38] Extended Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy with Anomalous Insertion of Chordae Tendineae
    Kargin, Ramazan
    Rabus, Murat Buelent
    Bitigen, Atila
    Ozdemir, Nihal
    Yakut, Cevat
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (10) : 1196.e3 - 1196.e4
  • [39] Secondary chordal resection with septal myectomy for treatment of symptomatic obstructive hypertrophic cardiomyopathy
    Ram, Eilon
    Schwammenthal, Ehud
    Kuperstein, Rafael
    Jamal, Tamer
    Nahum, Eyal
    Sternik, Leonid
    Raanani, Ehud
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 60 (03) : 699 - 707
  • [40] Surgery for Hypertrophic Obstructive Cardiomyopathy: Comprehensive LVOT Management beyond Septal Myectomy
    Affronti, Alessandro
    Pruna-Guillen, Robert
    Sandoval, Elena
    Pereda, Daniel
    Alcocer, Jorge
    Castella, Manuel
    Quintana, Eduard
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)